Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Xia YY, Gronwald J, Karlan B, Lubinski J, et al. Gynecol Oncol 2022 Jan 18. pii: S0090-8258(22)00022.

Read + Share

Amedeo Smart

Independent Medical Education

Xia YY, Gronwald J, Karlan B, Lubinski J, et al. Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 2022 Jan 18. pii: S0090-8258(22)00022.
PMID: 35063280